At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
Bilastine +1 moredrug
Likely dose
Bilastine 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study to Assess Oral Bioavailability of Bilastine (Estudio de Biodisponibilidad Oral de Bilastina)
In Brief
A Phase 1 clinical trial evaluating Bilastine for Healthy. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the absolute bioavailability of an oral bilastine formulation (test drug) compared to the endovenous administration of an IV bilastine formulation (control drug) in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesSpain
Collaborators--
Timeline
Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedMay 2010
Primary CompletionJun 2010
Study CompletionSep 2010
TodayJul 2026
First PostedMay 14, 2010
Enrollment StartMay 1, 2010
Primary CompletionJun 1, 2010
Study CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.1 years ago
Interventions
Bilastinedrug
20 mg oral tablet
Bilastinedrug
10 mg endovenous bilastine